abstract |
The invention relates to a combination therapy, preferably for use in the prophylactic and / or therapeutic treatment of particular inflammatory diseases of the digestive tract, in particular of the intestine. The combination therapeutic comprises at least one vitamin D receptor agonist (VDA) and at least one other active ingredient, but with the proviso that the combination therapy no content and / or active ingredient from the group of terpenes, monoterpenes, vasoconstrictors, alpha-sympathomimetics and / or their physiologically acceptable salts or derivatives. |